But there are other costs, such as your time and your money. That is the whole point of our interest in EGCG as a potentially low toxicity drug.
True, we do not expect too many risks in terms of toxicity. As we point out every time we review a new clinical trial, there are costs and rewards associated with participating in any clinical trial, and this one is no exception. We give you inclusion and exclusion criteria, time frames, contact information, names and phone numbers where you can get additional information. The first is our review of the clinical trial design, pros and cons. You can read more of the background of “Project Alpha” by clicking on this link: CLL Topics Sponsored Projects. I can keep going, but you get the picture. It is the first time that CLL Topics has taken on such a challenging task. It is the first time that a CLL patient group has sponsored and funded a clinical trial. It is the first time that a patient group has worked closely with a premier institution such as Mayo Clinic to bring to the forefront a low toxicity therapy approach that is of interest to the patient community. It is the first formal clinical trial using EGCG (an extract of green tea) as a potential drug for treating CLL, in human volunteers. This clinical trial has a number of “firsts”. Project Alpha begins recruiting patients today. Hundreds of generous donors have put their money where their hearts are and have contributed to our fund-raising efforts. It has been a long wait and has involved a lot of hard work on part of the researchers and even us chickens at CLL Topics. Related Articles: Project Alpha Proposal Project Alpha Announcement Project Alpha Milestones. By Chaya Venkat EGCG Trial Is on Its Way!
0 kommentar(er)
